HAAO and Huntington disease: Indeed, tryptophan and its degradation products have been proposed as pathogenic factors in Huntington brain, with the tryptophan metabolite quinolinate reported to be elevated in Huntington disease brain, due to increased 3-hydroxyanthranilate oxygenase activity [54].